PRESS RELEASE published on 05/12/2025 at 07:31, 1 year ago adesso SE increases sales by 11% to EUR 353.4 million in the first quarter of 2025 / EBITDA of EUR 17.8 million at the level of the previous year, which benefited from other operating income adesso SE reports 11% increase in sales to EUR 353.4 million in Q1 2025 with stable EBITDA of EUR 17.8 million, driven by digital transformation demand and market growth EBITDA Digital Transformation Sales Increase Adesso SE Q1 2025
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago EQS-WpÜG: Tender Offer / Target company: ProSiebenSat.1 Media SE; Bidder: PPF IM LTD PPF IM LTD announces public acquisition offer for up to 29.99% of ProSiebenSat.1 Media SE shares at EUR 7.00 per share. Offer subject to merger control clearances Shareholders Acquisition Offer Merger Control ProSiebenSat.1 Media SE PPF IM LTD
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago Salzgitter AG delivers a pre-tax result close to breakeven Salzgitter AG reports pre-tax result close to breakeven in Q1 2025 despite economic challenges and external sales decline. EBITDA at €78.6 million EBITDA Financial Report Salzgitter AG Pre-tax Result Q1 2025
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago q.beyond increases earnings and financial strength in Q1 2025 and confirms outlook q.beyond AG increases earnings by 15% in Q1 2025, reaching EBITDA of € 2.3 million. Free cash flow grows to € 0.8 million, with net liquidity at € 39.9 million. Full-year forecast for 2025 confirmed Q.beyond AG Financial Strength Forecast Earnings Q1 2025
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago IONOS with strong growth in the first quarter of 2025 – Outlook 2025 concretized IONOS Group SE reports strong growth in Q1 2025 with 80,000 new customers, 19.7% revenue increase, and 23.8% adjusted EBITDA rise. Outlook for 2025: approx. €520 million adjusted EBITDA Revenue Increase IONOS Group SE EBITDA Rise Q1 2025 2025 Outlook
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago L'homologation par la FDA américaine du colorant bleu naturel de Fermentalg ouvre la voie à une nouvelle génération de produits biosourcés pour l'industrie agro-alimentaire Fermentalg annonce l'homologation de son colorant bleu naturel par la FDA américaine, une avancée majeure pour l'industrie alimentaire. La commercialisation d'EverzureTM Galdieria promet des alternatives naturelles et durables FDA Industrie Alimentaire FERMENTALG Colorant Bleu Naturel Alternative Naturelle
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago The FDA's approval of Fermentalg's natural blue dye paves the way for a new generation of bio-based products in the food industry. Fermentalg's Everzure™ Galdieria, a natural blue dye approved by the FDA, offers innovative biosourced solution for food industry, replacing petroleum-based colorants FDA Approval Food Industry FERMENTALG Natural Blue Dye Everzure™ Galdieria
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago Klea Holding démarre fort le deuxième trimestre 2025 avec un nouveau record en avril pour sa filiale Smart Salem Smart Salem établit un nouveau record mensuel avec 18 497 tests en avril 2025, illustrant la croissance continue de l'entreprise. Klea Holding confirme sa stratégie de développement Croissance Performance Smart Salem Klea Holding Record Mensuel
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago Klea Holding mark strong start to Q2 2025 with new monthly record in April for its subsidiary Smart Salem Smart Salem, a subsidiary of Klea Holding, achieves a new monthly record by conducting 18,497 tests in April 2025, displaying a 94% year-on-year growth. Growth strategy in progress Growth Strategy Smart Salem Klea Holding Monthly Record Digitalized Medical Analysis
PRESS RELEASE published on 05/12/2025 at 07:30, 1 year ago Informations privilégiées / Autres communiqués MaaT Pharma annonce des données finales prometteuses pour son essai de Phase 1b évaluant MaaT033 dans la Sclérose Latérale Amyotrophique (SLA). Résultats encourageants et implications thérapeutiques importantes Microbiome Ecosystem Therapies MaaT Pharma Sclérose Latérale Amyotrophique Phase 1b Modulation Du Microbiote
Published on 05/16/2026 at 01:15, 1 day 12 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 14 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 15 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 15 hours ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 22 hours 6 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 18 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 20 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 23 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 23 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 4 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 5 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 20 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES